Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 290.69 | 45.57 |
| PEG Ratio (TTM) | 3.32 | 1.01 |
| P/S Ratio (TTM) | 1.95 | 17.12 |
| P/B Ratio (TTM) | 3.32 | 16.75 |
| P/FCF Ratio (TTM) | 5.59 | 40.14 |
| Price to 5YR AVG Earnings Ratio | N/A | 63.04 |
| Price to 5YR AVG FCF Ratio | N/A | 98.76 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.61% | -2.56% |
| ROE (TTM) | 1.19% | 10.12% |
| Net Profit Margin (TTM) | 0.65% | 4.50% |
| ROIC 5YR AVG | N/A | 3.39% |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 5.28% | 36.41% | N/A |
| Revenue | 5.31% | 82.04% | N/A |
| Net Income | 5.48% | -88.14% | N/A |
| Cash Flow | 16.27% | -45.75% | N/A |
Health (53%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 6.49 | 1.92 |
| Quick Ratio (TTM) | 5.81 | 1.91 |
| D/E Ratio (TTM) | 0.61 | 0.57 |
| Interest Coverage (TTM) | 0.73 | 11.84 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | 2.31 | 10.66 |
| LTL to 5YR AVG FCF | N/A | 3.74 |
| Shares Outstanding Growth 5YR AVG | N/A | 44.60% |